Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience

Author:

Lorent N.,De Leyn P.,Lievens Y.,Verbeken E.,Nackaerts K.,Dooms C.,Van Raemdonck D.,Anrys B.,Vansteenkiste J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference36 articles.

1. The role of surgery in N2 lung cancer;Martini;Surg Clin North Am,1987

2. N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 GY by the radiation therapy oncology group;Cox;Int J Radiat Oncol Biol Phys,1991

3. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung;Pearson;J Thorac Cardiovasc Surg,1982

4. Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases;Vansteenkiste;The Leuven Lung Cancer Group. Ann Thorac Surg,1997

5. Present status of induction treatment for N2 non-small cell lung cancer: A review;Vansteenkiste;Eur J Cardiothorac Surg,1998

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3